Records containing: Hepatitis C
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2016-04-21Personalized Medicine in HCV Infection: Cognitive Impairments and Brain Anomalies in Chronic Hepatitis C Infected Individuals. Characterization and Potential Reversibility With Direct Antiviral Agents.
-
CLINICAL_TRIALS study record update · 2016-04-20A Multicenter, Open-label, Randomized, 3-arm, Phase II Profiling Trial of Pharmacokinetics, Pharmacodynamics and Safety of DEB025/Alisporivir in Combination With Ribavirin Therapy in Chronic Hepatitis C Genotype 2 and 3 Treatment naïve Patients
-
CLINICAL_TRIALS study record update · 2016-04-19RHACE 1: Rapid HepAtitis C Elimination Trial - A Pilot Evaluation of Twice Daily Fixed Dose Combination Asunaprevir +Daclatasvir + BMS-791325 ± Weight Based Ribavirin in Treatment-Naïve, Non-cirrhotic Patients With Chronic Genotype 1a Hepatitis-C for Eight, Six or Four Weeks
-
CLINICAL_TRIALS study record update · 2016-04-11Hepatitis C Translating Initiatives for Depression Into Solutions
-
CLINICAL_TRIALS study record update · 2016-04-11Paroxetine for the Prevention of IFN-Alpha Associated Depression in Patients With Chronic Hepatitis C
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2016-04-08A Multicenter, Open Label, Pilot Study to Investigate Tolerability and Efficacy of MK5172 / MK8742 Without Ribavirin for 12 Weeks in Patients With Chronic HCV G1b Infection With Compensated Cirrhosis (Child-Pugh A5 to A6) and No Response to PR or Prior Failure to First Generation Protease Inhibitors (PIs)
-
CLINICAL_TRIALS study record update · 2016-04-08An Observational Follow-up Study of Patients Who Experienced Thromboembolic Events in the ENABLE Studies
-
CLINICAL_TRIALS study record update · 2016-04-04A Phase III, Open-Label, Single Arm, Rollover Trial of TMC435 in Combination With Peginterferon Alpha-2A and Ribavirin for HCV Genotype-1 Infected Subjects Who Participated in the Placebo Group of a Phase II/III TMC435 Study, or Who Received DAA Treatment in a Tibotec-Sponsored Phase I Study.
-
CLINICAL_TRIALS study record update · 2016-04-01Efficacy of 12 Week Boceprevir in Addition to Standard of Care Therapy Consisting of Peginterferon-alpha-2b and Ribavirin for the Treatment of Acute HCV Genotype 1 in HIV Co-infected Patients. A Proof of Concept Feasibility Clinical Trial.
-
CLINICAL_TRIALS study record update · 2016-03-29Efficacy of an Exercise Intervention to Decrease Depressive Symptoms in Veterans With Hepatitis C
-
CLINICAL_TRIALS study record update · 2016-03-04A Phase II Randomized Clinical Trial to Study the Efficacy and Safety of MK-5172 in Combination With Ribavirin (RBV) in Subjects With Chronic Hepatitis C Virus Infection
-
CLINICAL_TRIALS study record update · 2016-03-04A Multiple Dose Study to Evaluate Pharmacokinetics and Hepatitis C Virus RNA Dynamics Following Administration of MK-5172 in Hepatitis C Infected Patients
-
CLINICAL_TRIALS study record update · 2016-03-04An Open-label, 3-Part, Multiple Dose Study to Investigate the Influence of Hepatic Insufficiency on the Pharmacokinetics of Grazoprevir (MK-5172)
-
CLINICAL_TRIALS study record update · 2016-03-04A Phase II Clinical Trial to Evaluate the Efficacy and Safety of a Combination Regimen of MK-5172 With/Without MK-8742 and/or Ribavirin (RBV) in Treatment-naive Subjects With Chronic Hepatitis C Genotype 2, 4, 5 and 6 Infection
-
CLINICAL_TRIALS study record update · 2016-03-02A Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Grazoprevir (MK-5172) in Hepatitis C Infected Male Patients
-
CLINICAL_TRIALS study record update · 2016-02-24HCV/HIV Coinfection: Antiviral Therapy and Fibrosis
-
CLINICAL_TRIALS study record update · 2016-02-24A Phase 2, Multicenter, Open-Label, Randomized Study to Investigate the Safety and Efficacy of GS-7977 and Ribavirin Administered for 48 Weeks in Patients Infected With Chronic HCV With Cirrhosis and Portal Hypertension With or Without Liver Decompensation
-
CLINICAL_TRIALS study record update · 2016-02-22Retrieval of Patients Chronically Infected With Hepatitis B or Hepatitis C in Northern Holland
-
CLINICAL_TRIALS study record update · 2016-02-12Epidemiological Study to Evaluate the Management of Patients With Chronic Hepatitis C and Previous Treatment Failure
-
CLINICAL_TRIALS study record update · 2016-02-10A Non-Interventional Trial of Pegasys/Copegus in HCV Patients for 12 Months
-
CLINICAL_TRIALS study record update · 2016-02-05A Phase 3B Randomized, Open-Label, Multi-Center Trial Assessing Sofosbuvir + Ribavirin for 16 or 24 Weeks and Sofosbuvir + Pegylated Interferon + Ribavirin for 12 Weeks in Subjects With Genotype 2 or 3 Chronic HCV Infection.
-
CLINICAL_TRIALS study record update · 2016-02-04Collection of Plasma and Serum Samples From Individuals Initiating Therapy With Sofosbuvir for Chronic Hepatitis C Virus Infection for the Clinical Evaluation of the Aptima HCV Quant Dx Assay
-
CLINICAL_TRIALS study record update · 2016-02-04A Multiple Dose Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of MK-8876 in Hepatitis C Patients
-
CLINICAL_TRIALS study record update · 2016-01-29Double-Blind, Randomized, Placebo-controlled, Multi-center Trial to Determine the Safety and Antiviral Effect of Single Doses of EDP239 in Hepatitis C Virus (HCV) Infected Subjects
-
CLINICAL_TRIALS study record update · 2016-01-26A Phase I, Open-label Study to Evaluate the Relative Bioavailability of IDX184 and Food Effect in Healthy Male Subjects